| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.14▼ | 1.14▼ | 1.12▼ | 1.12▲ | 1.26▼ |
| MA10 | 1.14▼ | 1.13▼ | 1.13▼ | 1.19▼ | 1.40▼ |
| MA20 | 1.11▲ | 1.13▼ | 1.15▼ | 1.33▼ | 1.73▼ |
| MA50 | 1.19▼ | 1.19▼ | 1.26▼ | 1.48▼ | 2.04▼ |
| MA100 | 1.21▼ | 1.32▼ | 1.37▼ | 1.85▼ | 2.82▼ |
| MA200 | 1.33▼ | 1.42▼ | 1.50▼ | 2.02▼ | 2.40▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.007▲ | 0.010▲ | -0.019▼ | -0.055▼ |
| RSI | 47.067▼ | 45.936▼ | 44.570▼ | 29.476▼ | 27.986▼ |
| STOCH | 83.860▲ | 76.658 | 73.843 | 30.859 | 26.626 |
| WILL %R | -40.000 | -21.053▲ | -34.783 | -70.000 | -79.775▼ |
| CCI | -40.759 | 12.302 | 9.379 | -74.985 | -144.347▼ |
|
Thursday, December 11, 2025 04:00 PM
TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
|
|
Thursday, October 30, 2025 05:00 PM
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory ...
|
|
Tuesday, October 28, 2025 05:59 AM
(RTTNews) - Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, on Tuesday reported positive results from a Phase 3 study evaluating paridiprubart, its drug candidate for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 09/02/26 | 1.155 | 1.155 | 1.12 | 1.12 | 56,180 |
| 06/02/26 | 1.10 | 1.17 | 1.06 | 1.12 | 53,100 |
| 05/02/26 | 1.10 | 1.195 | 1.10 | 1.12 | 41,036 |
| 04/02/26 | 1.18 | 1.22 | 0.94 | 1.09 | 189,300 |
| 03/02/26 | 1.34 | 1.34 | 1.14 | 1.14 | 60,200 |
| 02/02/26 | 1.24 | 1.295 | 1.07 | 1.23 | 618,607 |
| 30/01/26 | 1.24 | 1.25 | 1.09 | 1.17 | 272,700 |
| 29/01/26 | 1.36 | 1.36 | 1.23 | 1.23 | 208,000 |
| 28/01/26 | 1.39 | 1.4099 | 1.34 | 1.34 | 107,722 |
| 27/01/26 | 1.45 | 1.45 | 1.38 | 1.38 | 104,631 |
|
|
||||
|
|
||||
|
|